Showing results (11-20 of 528) with videos related to

Sort By:
Pageof 53
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Characterizing structural uncertainty in decision analytic models: a review and application of methodsLaura Bojke, Karl Claxton, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2006
Probabilistic analysis and computationally expensive models: Necessary and required?Susan Griffin, Karl Claxton, Neil Hawkins, et al.
Intensive Care Medicine|May 25, 2002
Pre-operative optimisation employing dopexamine or adrenaline for patients undergoing major elective surgery: a cost-effectiveness analysisElisabeth Fenwick, Jonathan Wilson, Mark Sculpher, et al.
Health Economics|August 3, 2021
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systemsBeth Woods, Aimée Fox, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2016
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further ResearchBeth Woods, Paul Revill, Mark Sculpher, et al.
Health Economics|December 10, 2014
Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?Karl Claxton, Mark Sculpher, Stephen Palmer, et al.
Health Economics|October 5, 2017
Social value and individual choice: The value of a choice-based decision-making process in a collectively funded health systemManuel Antonio Espinoza, Andrea Manca, Karl Claxton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 6, 2007
Efficiency, equity, and budgetary policies: informing decisions using mathematical programmingDavid M Epstein, Zaid Chalabi, Karl Claxton, et al.
Pharmacoeconomics|April 12, 2006
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessmentZoë Philips, Laura Bojke, Mark Sculpher, et al.
Health Economics|January 16, 2024
Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments requiredBeth Woods, James Lomas, Mark Sculpher, et al.
Pageof 53